Amedisys Inc  

(Public, NASDAQ:AMED)   Watch this stock  
Find more results for LARRY PERKINS
40.43
-0.71 (-1.73%)
Sep 3 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 40.33 - 42.65
52 week 19.03 - 48.34
Open 41.21
Vol / Avg. 236,811.00/420,289.00
Mkt cap 1.39B
P/E     -
Div/yield     -
EPS -0.22
Shares 33.67M
Beta 1.19
Inst. own 88%
Oct 27, 2015
Q3 2015 Amedisys Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 10, 2015
Amedisys Inc at Robert W Baird and Co Health Care Conference - 2:00PM EDT - Add to calendar
Sep 9, 2015
Amedisys Inc at Wells Fargo Healthcare Conference - 10:00AM EDT - Add to calendar
Jul 29, 2015
Q2 2015 Amedisys Inc Earnings Call - Webcast
Jul 29, 2015
Q2 2015 Amedisys Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 3.46% 1.10%
Operating margin 4.94% 2.00%
EBITD margin - 4.61%
Return on average assets 6.87% 1.91%
Return on average equity 11.44% 3.38%
Employees 13,200 -
CDP Score - -

Address

5959 S SHERWOOD FOREST BLVD
BATON ROUGE, LA 70816
United States - Map
+1-225-2922031 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Amedisys, Inc. (Amedisys) is a health care at home company. Amedisys delivers home health and hospice care to more than 360,000 patients each year. The Company has care network across 34 states. As of December 31, 2014, it owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers. The Company operates through two segments: home health and hospice. The Company’s home health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with the essential activities of daily living. The Company’s hospice segment provides palliative care and comfort to terminally ill patients and their families.

Officers and directors

Paul B K Kusserow President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Ronald A. LaBorde Vice Chairman of the Board, Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Dan McCoy Chief Operating Officer
Bio & Compensation  - Reuters
Larry Pernosky Chief Human Resource Officer
Bio & Compensation  - Reuters
David L. Kemmerly Senior Vice President - Government Affairs, Interim General
Bio & Compensation  - Reuters
Martin Howard Chief Information Officer
Bio & Compensation  - Reuters
Jeffrey D. Jeter J.D. Chief Compliance Officer
Age: 43
Bio & Compensation  - Reuters
Stephen Seim Chief Strategy Officer
Bio & Compensation  - Reuters
Donald A. Washburn Non-Executive Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Linda J. Hall Independent Director
Age: 66
Bio & Compensation  - Reuters